Skip to forum content
cholangiocarcinoma.org :: discussion boards
a resource for patients, friends, caregivers and loved ones.
You are not logged in. Please login or register.
Active topics Unanswered topics
discussion boards → New Developments → Abstract B243: A phase I dose-escalation study of MEK inhibitor MEK162
You must login or register to post a reply
Topic RSS feed
Abstract B243: A phase I dose-escalation study of MEK inhibitor MEK162 (ARRY-438162) in patients with advanced solid tumors.
http://mct.aacrjournals.org/cgi/content … B243?rss=1
Like the Cholangiocarcinoma Foundation? Share us on Facebook.
Powered by PunBB 1.4.2, supported by Informer Technologies, Inc.
The pun_posts_feed official extension is installed. Copyright © 2003–2010 PunBB.